Member Info for Nolupus

So , joined the club here yesterday at 35

Waiting on the news from here on :-)

L1 or Lind , take your pick ....

Pullback to 9p and then we should see an upward movement IMO

Wait and see

Eva ,

You are biased :-).

Tils and Evg are multibaggers ....

Sng will never see 250 again

85p. Each

First to 200 will win

Johny,

It’s in nobody’s interest that the Sp goes below a certain level from now on so I will disagree with your bloodbath :-)

But everyone to their own convictions

Next week ,
L1 and Lind should be finished selling their converted shares IMO
Then we can look forward to some rise in the sp as we approach the FDA deadline ...

Eyes to the stars but feet on the ground :-)

What’s cooking Doc ?

9.28. —-9.30

Let’s wait and see

Dallo,

The only thing for sure is that IMm are still losing money on their investment in Incanthera ...and we shareholders were immensely diluted to fund that investment

Thanks Tim

Dallo,

Could you ask Chairman Tim to buy some shares on the market at 13p ? :-))

Sicilian kan ,

It might also mean that they aren’t expecting any P3 results before the 3 year period ....

The exercise price for the Options is 20p being a 54% premium to the closing middle market share price of 13p on 25 November 2020. The Options will vest after three years and are exercisable between three and ten years from the date of grant.

Dallo,

Thank you , I stand corrected

175 at the moment

Where is the support level, guys ?

No stock options for the new COO ?

Only the directors ...

Waiting on the multibagger :-)

L1 get their conversion shares tomorrow and Lind on Friday

Let’s see the volume over the next few days ...

Two weeks ....just in time for

A Christmas present ?

Dallo,

If the trial design was flawed for US patients it would also be flawed for European patients ...

Let’s stay logical and factual ....

Dallo,

The newly appointed COO was in fact an advisor to IMM for a while ...
Dimitri spends his time in Switzerland so they needed someone to mind the phones in case , some Big Pharma rang to buy a licence ...IMO